Iodixanol 270

Manufactured by GE Healthcare

Sourced in United Kingdom

Iodixanol 270 is a non-ionic, iso-osmolar contrast agent used in diagnostic imaging procedures. It is a water-soluble compound with a molecular weight of 1550 Da. Iodixanol 270 provides contrast enhancement in various imaging modalities, including computed tomography (CT) and magnetic resonance imaging (MRI).

Automatically generated - may contain errors

Lab products found in correlation

Iopamidol 350, by Bracco (2 mentions) Iobitridol 350, by Guerbet (2 mentions) Ge lightspeed vct, by GE Healthcare (2 mentions) Iopromide 370, by Bayer (2 mentions) Ioversol 320, by Jiangsu Hengrui Medicine (1 mentions)

Spelling variants of this product

Iodixanol (30 citations)

2 protocols using iodixanol 270

Contrast-enhanced CT Imaging Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols

GE LightSpeed VCT^® (GE Healthcare, Milwaukee, WI) and Philips Brilliance iCT Scanner (Royal Dutch Philips Electronics Ltd, Amsterdam, The Netherlands) were used for CT scanning. Nonionic iodinated contrast media were intravenously injected by a high-pressure injector (Ulrich Medical^® Inc.). The ICM used included Iopromide 370 (Bayer Healthcare), Iodixanol 270 (GE Healthcare), Ioversol 320 (Jiangsu Hengrui Medicine Co., Ltd), Iohexol 350 (Yangtze River Pharmaceutical Co., Ltd), Iopamidol 350 (Bracco), Iobitridol 350 (Guerbet), and Iodixanol 320(Jiangsu Hengrui Medicine Co., Ltd). The injection doses and rates of ICM were selected according to patient weight and the purpose of CT examinations, based on our institutional protocol (Additional file 1: Table S1).

Liu H., Zhao L., Liu J., Lan F., Cai L., Fang J, & Li X. (2022). Change the preprocedural fasting policy for contrast-enhanced CT: results of 127,200 cases. Insights into Imaging, 13, 29.

+ Open protocol

+ Expand

Contrast-Enhanced CT Imaging Protocols

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

Philips Brilliance iCT Scanner (Royal Dutch Philips Electronics Ltd, Amsterdam, The Netherlands) and GE LightSpeed VCT® (GE Healthcare, Milwaukee, WI, USA) were used for CECT examinations. Non-ionic ICM were intravenously injected by a high-pressure injector (Ulrich Medical® Inc., Ulm, Germany). The injection doses and injection rates of ICM were adopted according to our institutional protocol [16 (link)]. The ICM used included Iodixanol 270 (GE Healthcare, London, UK), Ioversol 320 (Jiangsu Hengrui Medicine Co., Ltd, Jiangsu, China), Iodixanol 320 (Jiangsu Hengrui Medicine Co., Jiangsu, China), Iohexol 350 (Yangtze River Pharmaceutical Co., Ltd, Jiangsu, China), Iopamidol 350 (Bracco, Milan, Italy), Iobitridol 350 (Guerbet, Paris, France), and Iopromide 370 (Bayer Healthcare, Leverkusen, Germany).

Liu H., Qiu H., Liu J., Wang L., Zhao L., Wang Y, & Li X. (2023). Stratified assessment and warning regimen for prevention of acute adverse reactions to iodinated contrast media: results of 150,343 cases in a tertiary hospital. Medical & Biological Engineering & Computing, 61(3), 709-720.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!